Halozyme Reports Fourth Quarter and Full Year 2019 Results

Go back to Halozyme Reports Fourth Quarter and Full Year 2019 Results
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 70.13 +1.14 (1.65%)
Previous Close $68.99    52 Week High $18.39 
Open $69.38    52 Week Low $6.96 
Day High $70.21    P/E N/A 
Day Low $68.93    EPS $-0.58 
Volume 475,649